Risankizumab Antibody
Risankizumab is a high-affinity humanized monoclonal antibody targeting the IL-23 p19 subunit, potently inhibiting IL-23-driven IL-17 production with an IC50 of 2 pM in vitro. It is a key research tool for studying Th17-mediated pathologies like psoriasis and psoriatic arthritis, with applications in both cellular assays and preclinical in vivo models.
Product Specifications
Product Name Alternative
ILReceptor, IL Receptor, IL-23, BI-655066, ABBV 066, SKYRIZI, Risankizumab rzaa
Target
Interleukin, IL Receptor
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
3.93 mg/mL
Purity
95.30% (May vary between batches)
Molecular Weight
145.85 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![UBA3 Mouse Monoclonal Antibody [1C10-5-5]](https://cdn.genprice.uk/products/992/68dd1c8e061270361ea82446/imageurl/em1901-65.webp)
Human Lipolysis Stimulated Lipoprotein Receptor (LSR) ELISA Kit
Human Lipolysis Stimulated Lipoprotein Receptor (LSR) ELISA Kit
Recombinant Human Tryptophan 2,3-dioxygenase Protein, His, Yeast-1mg